Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6116495 | Diagnostic Microbiology and Infectious Disease | 2012 | 6 Pages |
Abstract
All isolates were inhibited by low concentrations of the fluoroquinolones and macrolides tested, with somewhat higher MICs for the fluoroquinolones. Rifampicin was found to be the most active against L. pneumophila isolates in vitro. These data can be used as a reference for the detection of resistance in clinical L. pneumophila isolates and as a setting of clinical breakpoints.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Jacob P. Bruin, Ed P.F. Ijzerman, Jeroen W. den Boer, Johan W. Mouton, Bram M.W. Diederen,